Sort   by:  
 Page size 
UnknownVEGF blockade enhances the antitumor effect of BRAFV600E inhibition.
Not available
S-EPMC5286370 | biostudies-literature
UnknownCytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy.
Not available
S-EPMC7999072 | biostudies-literature
UnknownMET Oncogene Targeting for Cancer Immunotherapy.
Not available
S-EPMC11173045 | biostudies-literature
UnknownBiological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19.
Not available
S-EPMC9599827 | biostudies-literature
UnknownNext generation immune-checkpoints for cancer therapy.
Not available
S-EPMC5994499 | biostudies-literature
UnknownCellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective.
Not available
S-EPMC8001974 | biostudies-literature
UnknownAdoptive immunotherapy against ovarian cancer.
Not available
S-EPMC4869278 | biostudies-literature
UnknownRepurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer.
Not available
S-EPMC11616334 | biostudies-literature
UnknownCAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy.
Not available
S-EPMC6600566 | biostudies-literature
UnknownBaseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment.
Not available
S-EPMC10649732 | biostudies-literature
Sort   by:  
 Page size